A helpful subset of the intestinal microbiome, lactobacilli, stimulates the cytoprotective Nrf2 pathway in both flies and mice. The findings could potentially lead to advances in the use of bacteria to treat intestinal diseases or mitigate the effects of radiation therapy for cancer. “The body’s response to bacteria is often seen through the lens of the immune system,” says Prof. Andrew Neish, MD. “The pathway we’ve identified is not inflammatory or immunoregulatory; rather, it’s cytoprotective.”
While many types of bacteria that live in our intestines are inert or even h...
Read More
Recent Comments